Geographic Atrophy Secondary to Age-related Macular Degeneration

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-30
Clinical Trial Update: A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio [Phase 2]
Phase 2 randomized, placebo-controlled trial evaluating multidose APL-3007 in combination with pegylated complement inhibitor Syfovre (pegce…
CLINICAL_TRIALS research · 2025-12-09
Clinical Trial Update: A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating KRIYA-825 (VV-14295) for geographic atrophy due to age-related macular degeneration is currently recru…